The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures
Open accessAbstract
Fragile X syndrome (FXS) results in intellectual disability (ID) most often caused by silencing of the fragile X mental retardation 1 (FMR1) gene. The resulting absence of fragile X mental retardation protein 1 (FMRP) leads to both pre- and postsynaptic defects, yet whether the pre- and postsynaptic functions of FMRP are independent and have distinct roles in FXS neuropathology remain poorly understood. Here, we demonstrate an independent presynaptic function for FMRP through the study of an ID patient with an FMR1 missense mutation. This mutation, c.413G > A (R138Q), preserves FMRP's canonical functions in RNA binding and translational regulation, which are traditionally associated with postsynaptic compartments. However, neuronally driven expression of the mutant FMRP is unable to rescue structural defects at the neuromuscular junction in fragile x mental retardation 1 (dfmr1)-deficient Drosophila, suggesting a presynaptic-specific impairment. Furthermore, mutant FMRP loses the ability to rescue presynaptic action potential (AP) broadening in Fmr1 KO mice. The R138Q mutation also disrupts FMRP's interaction with the large-conductance calcium-activated potassium (BK) channels that modulate AP width. These results reveal a presynaptic- and translation-independent function of FMRP that is linked to a specific subset of FXS phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and a translation-independent function was also described for FMRP (Myrick et al., 2015).”
From New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes (2017) · cites this paper as Myrick et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Self-citationAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349
Self-citationFragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Self-citationZhang, Y., Bailey, A. M., Matthies, H. J. G., Renden, R., Smith, M. A., Speese, S. D., Rubin, G. M., & Broadie, K. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00589-x · Cited by 651
A point mutation in the FMR-1 gene associated with fragile X mental retardation
Boulle, K. D., Verkerk, A. J. M. H., Reyniers, E., Vits, L., Hendrickx, J., Roy, B. V., Bos, F. V. D., de Graaff, E., Oostra, B. A., & Willems, P. J. (1993) · Nature Genetics · doi:10.1038/ng0193-31 · Cited by 624
Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder
Du, W., Bautista, J. F., Yang, H., Dı́ez-Sampedro, A., You, S.-A., Wang, L., Kotagal, P., Lüders, H. O., Shi, J., Cui, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1585 · Cited by 578
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Santoro, M. R., Bray, S. M., & Warren, S. T. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132457 · Cited by 528
Self-citationThe Tudor domain ‘Royal Family’: Tudor, plant Agenet, Chromo, PWWP and MBT domains
Maurer‐Stroh, S., Dickens, N. J., Hughes‐Davies, L., Kouzarides, T., Eisenhaber, F., & Ponting, C. P. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00004-5 · Cited by 482
Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression
Lan, F., Collins, R. E., Cegli, R. D., Alpatov, R., Horton, J. R., Shi, X., Gozani, O., Cheng, X., & Shi, Y. (2007) · Nature · doi:10.1038/nature06034 · Cited by 432
Self-citationMuddashetty, R. S., Kelić, S., Gross, C., Xu, M., & Bassell, G. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0937-07.2007 · Cited by 421
Cited by
Sorted by citations
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Altered Neuronal and Circuit Excitability in Fragile X Syndrome
Contractor, A., Klyachko, V. A., & Portera‐Cailliau, C. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.017 · Cited by 418
Self-citationDysregulation and restoration of translational homeostasis in fragile X syndrome
Richter, J. D., Bassell, G. J., & Klann, E. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4001 · Cited by 275
BK Channels in the Central Nervous System
Contet, C., Goulding, S. P., Kuljis, D. A., & Barth, A. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.04.001 · Cited by 180
Sensory Processing Phenotypes in Fragile X Syndrome
Rais, M., Binder, D. K., Razak, K. A., & Ethell, I. M. (2018) · ASN NEURO · doi:10.1177/1759091418801092 · Cited by 143
The role of TGF-β superfamily signaling in neurological disorders
Kashima, R., & Hata, A. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 130
Of Men and Mice: Modeling the Fragile X Syndrome
Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 133
Multifarious Functions of the Fragile X Mental Retardation Protein
Davis, J. K., & Broadie, K. S. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.07.008 · Cited by 118
Human FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain
Myrick, L. K., Hashimoto, H., Cheng, X., & Warren, S. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu586 · Cited by 122
Self-citationTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
Channelopathies in fragile X syndrome
Deng, P., & Klyachko, V. A. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00445-9 · Cited by 112
Self-citationRare FMR1 gene mutations causing fragile X syndrome: A review
Sitzmann, A. F., Hagelstrom, R. T., Tassone, F., Hagerman, R. J., & Butler, M. G. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38504 · Cited by 91
Hippocampal deficits in neurodevelopmental disorders
Li, Y., Shen, M., Stockton, M. E., & Zhao, X. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.10.001 · Cited by 89
Lovelace, J. W., Rais, M., Palacios, A. R., Shuai, X. S., Bishay, S., Popa, O., Pirbhoy, P. S., Binder, D. K., Nelson, D. L., Ethell, I. M., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz141 · Cited by 82
Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome
Tang, B., Wang, T., Wan, H., Han, L., Qin, X., Zhang, Y., Wang, J., Yu, C., Berton, F., Francesconi, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502258112 · Cited by 84
Bonnycastle, K., Davenport, E. C., & Cousin, M. A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15035 · Cited by 78
Deng, P., & Klyachko, V. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.046 · Cited by 79
Self-citationSumoylation regulates FMRP-mediated dendritic spine elimination and maturation
Khayachi, A., Gwizdek, C., Poupon, G., Alcor, D., Chafaï, M., Cassé, F., Maurin, T., Prieto, M. C., Folci, A., Graeve, F. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03222-y · Cited by 85
Fragile X mental retardation protein controls ion channel expression and activity
Ferron, L. (2016) · The Journal of Physiology · doi:10.1113/jp270675 · Cited by 80
Deng, P., & Klyachko, V. A. (2015) · The Journal of Physiology · doi:10.1113/jp271031 · Cited by 73
Self-citationGriguoli, M., Sgritta, M., & Cherubini, E. (2016) · The Journal of Physiology · doi:10.1113/jp271841 · Cited by 71
Functional Deficiencies in Fragile X Neurons Derived from Human Embryonic Stem Cells
Telias, M., Kuznitsov-Yanovsky, L., Segal, M., & Ben‐Yosef, D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0317-15.2015 · Cited by 69
Modeling Fragile X Syndrome in Drosophila
Drozd, M. M., Bardoni, B., & Capovilla, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00124 · Cited by 70
Mechanisms underlying auditory processing deficits in Fragile X syndrome
McCullagh, E. A., Rotschafer, S. E., Auerbach, B. D., Klug, A., Kaczmarek, L. K., Cramer, K. S., Kulesza, R. J., Razak, K. A., Lovelace, J. W., Lu, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902435r · Cited by 66
Deng, P., Carlin, D., Oh, Y. M., Myrick, L. K., Warren, S. T., Cavalli, V., & Klyachko, V. A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1593-18.2018 · Cited by 60
Self-citationAbekhoukh, S., Sahin, H. B., Grossi, M., Zongaro, S., Maurin, T., Madrigal, I., Kazue-Sugioka, D., Raas-Rothschild, A., Doulazmi, M., Carrera, P., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.025809 · Cited by 59
“Indeed, FMRP is not only involved in translational repression, it is also a translational enhancer (Bechara et al., 2009; Gross et al., 2011; Kwan et al., 2012; Tabet et al., 2016) and a translation-independent function was also described for FMRP (Myrick et al., 2015).”
Modulators of Kv3 Potassium Channels Rescue the Auditory Function of Fragile X Mice
El‐Hassar, L., Song, L., Tan, W. J. T., Large, C., Alvaro, G. S., Santos-Sacchi, J., & Kaczmarek, L. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0839-18.2019 · Cited by 60
FMR1 and Autism, an Intriguing Connection Revisited
Fyke, W., & Velinov, M. T. (2021) · Genes · doi:10.3390/genes12081218 · Cited by 60
Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brains
Akins, M. R., Berk-Rauch, H., Kwan, K. Y., Mitchell, M. E., Shepard, K. A., Korsak, L. I. T., Stackpole, E. E., Warner‐Schmidt, J. L., Šestan, N., Cameron, H. A., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw381 · Cited by 56
Hyperexcitability and homeostasis in fragile X Syndrome.
Liu, X., Kumar, V., Tsai, N.-P., & Auerbach, B. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.805929 · Cited by 53
Berry‐Kravis, E., Filipink, R. A., Frye, R. E., Golla, S., Morris, S. M., Andrews, H., Choo, T.-H. J., & Kaufmann, W. E. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.736255 · Cited by 50
Large conductance voltage-and calcium-activated K+ (BK) channel in health and disease
Echeverría, F., González-Sanabria, N., Alvarado-Sánchez, R., Fernández, M., Castillo, K., & Latorre, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1373507 · Cited by 44
Suhl, J. A., & Warren, S. T. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25524 · Cited by 43
Self-citationCereblon Maintains Synaptic and Cognitive Function by Regulating BK Channel
Choi, T.-Y., Lee, S., Kim, Y.-J., Bae, J. R., Lee, K. M., Jo, Y., Kim, S., Lee, A.-R., Choi, S., Choi, L., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2081-17.2018 · Cited by 42
The Fragile X Protein and Genome Function
Dockendorff, T. C., & Labrador, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1122-9 · Cited by 41
Prieto, M., Folci, A., Poupon, G., Schiavi, S., Buzzelli, V., Pronot, M., François, U., Pousinha, P. A., Lattuada, N., Abélanet, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21820-1 · Cited by 46
GABABreceptor‐mediated feed‐forward circuit dysfunction in the mouse model of fragile X syndrome
Wahlstrom‐Helgren, S., & Klyachko, V. A. (2015) · The Journal of Physiology · doi:10.1113/jp271190 · Cited by 40
Self-citationCarreño-Muñoz, M. I., Martins, F., Medrano, M., Aloisi, E., Pietropaolo, S., Dechaud, C., Subashi, E., Bony, G., Ginger, M. R., Moujahid, A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.149 · Cited by 44
Prieto, M., Folci, A., & Martin, S. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0629-4 · Cited by 44
Bodaleo, F. J., & González-Billault, C. E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00060 · Cited by 40
Doll, C. A., & Broadie, K. S. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.006 · Cited by 39
Geng, J., Khaket, T. P., Pan, J., Li, W., Zhang, Y., Ping, Y., Cobos, I., & Lu, B. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.03.002 · Cited by 37
Harper, C. B., Mancini, G. M. S., van Slegtenhorst, M., & Cousin, M. A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.021 · Cited by 36
Excitability is increased in hippocampal CA1 pyramidal cells of Fmr1 knockout mice
Luque, M. A., Beltrán‐Matas, P., Marin, M. C., Torres, B., & Herrero, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185067 · Cited by 32
Differential regulation of BK channels by fragile X mental retardation protein
Kshatri, A. S., Cerrada, A., Gimeno, R., Bartolomé‐Martín, D., Rojas, P., & Giráldez, T. (2020) · The Journal of General Physiology · doi:10.1085/jgp.201912502 · Cited by 31
Song, T., Liang, S., Liu, J., Zhang, T., Yin, Y., Geng, C., Gao, S., Feng, Y., Xu, H., Guo, D., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007165 · Cited by 31
Suhl, J. A., Muddashetty, R. S., Anderson, B. R., Ifrim, M. F., Visootsak, J., Bassell, G. J., & Warren, S. T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514260112 · Cited by 33
Self-citationRNA Secondary Structure Modulates FMRP’s Bi-Functional Role in the MicroRNA Pathway
Kenny, P., & Ceman, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060985 · Cited by 31
Golden, C. E. M., Breen, M. S., Koro, L., Sonar, S., Niblo, K., Browne, A., Burlant, N., Di Marino, D., De Rubeis, S., Baxter, M. G., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz029 · Cited by 29
New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons
Castagnola, S., Delhaye, S., Folci, A., Paquet, A. C., Brau, F., Duprat, F., Jarjat, M., Grossi, M., Béal, M., Martin, S., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00342 · Cited by 30
Mouse models of fragile X-related disorders
Willemsen, R., & Kooy, R. F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049485 · Cited by 30
Wang, T., de Kok, L. G. C., Willemsen, R., Elgersma, Y., & Borst, J. G. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00234 · Cited by 31
FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
Bleuzé, L., Triaca, V., & Borreca, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.699613 · Cited by 28
Gribkoff, V. K., & Winquist, R. J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115413 · Cited by 27
Handling FMRP and its molecular partners: Structural insights into Fragile X Syndrome
D’Annessa, I., Cicconardi, F., & Marino, D. D. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.07.001 · Cited by 31
Fragile X mental retardation protein: from autism to neurodegenerative disease
Wang, H. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00043 · Cited by 26
Synaptic vesicle dynamic changes in a model of fragile X
Broek, J. A. C., Lin, Z., de Gruiter, H. M., Spijker, H. M. V. ‘., Haasdijk, E. D., Cox, D., Özcan, S., van Cappellen, G. W. A., Houtsmuller, A. B., Willemsen, R., et al. (2016) · Molecular Autism · doi:10.1186/s13229-016-0080-1 · Cited by 22
Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome
Gray, E. E., Murphy, J. G., Liu, Y., Trang, I., Tabor, G. T., Lin, L., & Hoffman, D. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1443-17.2019 · Cited by 21
Khouri, E. E., Ghoumid, J., Haye, D., Giuliano, F., Drévillon, L., Briand‐Suleau, A., de la Grange, P., Nau, V., Gaillon, T., Bienvenu, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01072-7 · Cited by 20
Jacobs, S. A., Cheng, C., & Doering, L. C. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.011 · Cited by 25
Zeidler, S., de Boer, H., Hukema, R. K., & Willemsen, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00368 · Cited by 23
FMRP Sustains Presynaptic Function via Control of Activity-Dependent Bulk Endocytosis
Bonnycastle, K., Kind, P. C., & Cousin, M. A. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0852-21.2021 · Cited by 23
Deng, P., Kumar, A., Cavalli, V., & Klyachko, V. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110820 · Cited by 19
Self-citationOlesnicky, E. C., & Wright, E. G. (2018) · Journal of Developmental Biology · doi:10.3390/jdb6030021 · Cited by 18
Structural and Functional Abnormalities in the Olfactory System of Fragile X Syndrome Models
Bodaleo, F. J., Tapia-Monsalves, C., Rio, C. A. C.-D., González-Billault, C. E., & Nunez-Parra, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00135 · Cited by 17
Sears, J. C., & Broadie, K. S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108266 · Cited by 18
Tekendo‐Ngongang, C., Grochowsky, A. R., Solomon, B. D., & Yano, S. T. (2021) · Genes · doi:10.3390/genes12111669 · Cited by 17
FXS causing missense mutations disrupt FMRP granule formation, dynamics, and function
Starke, E. L., Zius, K., & Barbee, S. A. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010084 · Cited by 17
Zaidman, N. A., Panoskaltsis‐Mortari, A., & O’Grady, S. M. (2017) · The Journal of Physiology · doi:10.1113/jp274200 · Cited by 16
The quest for targeted therapy in fragile X syndrome
Zeidler, S., Hukema, R. K., & Willemsen, R. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1079176 · Cited by 15
Axonal and presynaptic FMRP: Localization, signal, and functional implications
Wang, X., Sela‐Donenfeld, D., & Wang, Y. (2023) · Hearing Research · doi:10.1016/j.heares.2023.108720 · Cited by 13
Mitchell, M. E., Cook, L. C., Shiers, S. I., Tavares‐Ferreira, D., Akopian, A. N., Dussor, G. O., & Price, T. J. (2023) · The Journal of Comparative Neurology · doi:10.1002/cne.25463 · Cited by 12
In Silico Analysis of FMR1 Gene Missense SNPs
Tekcan, A. (2016) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-016-0722-0 · Cited by 13
Yang, Y., Yang, G., Jiang, D., Lin, N., Kim, H. J., Jeon, N. L., Lau, A., Chen, L., & Lin, M. Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812056116 · Cited by 10
García-Font, N., Martín, R., Torres, M., Oset‐Gasque, M. J., & Sánchez‐Prieto, J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104482 · Cited by 10
A missense variant in the nuclear export signal of the FMR1 gene causes intellectual disability
Zeidler, S., Severijnen, L.-A. W. F. M., de Boer, H., van der Toorn, E. C., Ruivenkamp, C. A. L., Bijlsma, E. K., & Willemsen, R. (2020) · Gene · doi:10.1016/j.gene.2020.145298 · Cited by 11
D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., & Catania, M. V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105731 · Cited by 11
MiR-219 represses expression of dFMR1 in Drosophila melanogaster
Wang, C., Ge, L., Wu, J., Wang, X., & Yuan, L. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.008 · Cited by 8
The SZT2 Interactome Unravels New Functions of the KICSTOR Complex
Cattelani, C., Lesiak, D., Liebscher, G., Singer, I. I., Stasyk, T., Wallnöfer, M. H., Heberle, A. M., Corti, C., Hess, M. W., Pfaller, K., et al. (2021) · Cells · doi:10.3390/cells10102711 · Cited by 10
Eshraghi, M., Karunadharma, P. P., Blin, J., Shahani, N., Ricci, E. P., Michel, A. M., Urban, N. T., Galli, N., Rao, S. R., Sharma, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/629667 · Cited by 9
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome
Ferraguto, C., Piquemal, M., Lemaire, V., Moreau, M. M., Trazzi, S., Uguagliati, B., Ciani, E., Bertrand, S. S., Louette, E., Bontempi, B., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01956-6 · Cited by 7
Presentation of a recurrent FMR1 missense mutation (R138Q) in an affected female
Diaz, J., Scheiner, C., & Leon, E. L. (2018) · Translational Science of Rare Diseases · doi:10.3233/trd-180028 · Cited by 8
Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice
Hurley, M. J., Deacon, R. M. J., Chan, A. W. E., Baker, D., Selwood, D. L., & Cogram, P. (2021) · Brain · doi:10.1093/brain/awab246 · Cited by 8
Malone, T. J., Wu, J., Zhang, Y., Licznerski, P., Chen, R., Nahiyan, S., Pedram, M., Jonas, E. A., & Kaczmarek, L. K. (2025) · Science Advances · doi:10.1126/sciadv.adv3140 · Cited by 10
Wahlstrom‐Helgren, S., & Klyachko, V. A. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00413.2016 · Cited by 7
Self-citationFrom Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research
van der Lei, M. B., & Kooy, R. F. (2025) · Biomedicines · doi:10.3390/biomedicines13040805 · Cited by 6
Sun, F., Wang, H., Wu, J., Quraishi, I. H., Zhang, Y., Pedram, M., Gao, B., Jonas, E. A., Nguyen, V., Wu, S., et al. (2024) · Biomolecules · doi:10.3390/biom14111397 · Cited by 5
Bonnycastle, K., Nawaz, M. S., Kind, P. C., & Cousin, M. A. (2025) · Molecular Autism · doi:10.1186/s13229-025-00660-6 · Cited by 6
Mangano, G. D., Fontana, A., Salpietro, V., Antona, V., Mangano, G. R., & Nardello, R. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104441 · Cited by 5
Ferreira, J. F. B., Batista, J. D. S., & Fantin, C. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920180882 · Cited by 5
Perche, O., Lesne, F., Patat, A. A., Raab, S., Twyman, R. E., Ring, R. H., & Briault, S. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03387-7 · Cited by 5
Santorelli, D., Troilo, F., Fata, F., Angelucci, F., Demitri, N., Giardina, G., Federici, L., Catalano, F., Matteo, A. D., & Travaglini‐Allocatelli, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012178 · Cited by 4
Zhou, Y., Long, J., Fu, J., Sun, W., Hu, F., Huang, H.-Y., Li, W., Gao, M., Shu, Y., Yi, Y., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.01.028 · Cited by 4
Epidemiology of Fragile X Syndrome
Sherman, S. L., & Hunter, J. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00004-4 · Cited by 4
Nelson, D. L., Santoro, M. R., & Warren, S. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00002-0 · Cited by 3
Self-citationCarion, N., Briand‐Suleau, A., Cuisset, L., Pacot, L., Afenjar, A., & Bienvenu, T. (2020) · Gene · doi:10.1016/j.gene.2020.144793 · Cited by 4
RNA and Protein Targets of FMRP
Suhl, J. A., & Hoeffer, C. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00008-1 · Cited by 3
Self-citationGingrich, E. C., Shepard, K. A., Mitchell, M. E., Sawicka, K., Darnell, J. C., & Akins, M. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462168 · Cited by 3
FMR1 genetically interacts with DISC1 to regulate glutamatergic synaptogenesis
Honda, T., Kurita, K., Arai, Y., Pandey, H., Sawa, A., & Furukubo-Tokunaga, K. (2024) · Schizophrenia · doi:10.1038/s41537-024-00532-7 · Cited by 2
FMR1 KH0-KH1 domains coordinate m6A binding and phase separation in Fragile X syndrome
Zhou, X., Guo, C.-J., Wang, R. Y., Li, Y., Zhang, T., Qiu, Z., Gao, S., Liu, J., & Gao, Y. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114664 · Cited by 2
Metadata
- Authors
- Myrick, L. K., Deng, P.-Y., Hashimoto, H., Oh, Y. M., Cho, Y., Poidevin, M. J., Suhl, J. A., Visootsak, J., Cavalli, V., Jin, P., Cheng, X., Warren, S. T., & Klyachko, V. A.
- Affiliations
- Emory University (US)
- Departments of bBiomedical Engineering and Cell Biology and Physiology and
- Washington University in St. Louis (US)
- Departments of aHuman Genetics,
- Biochemistry, and
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-01-05
- Volume
- 112
- Issue
- 4
- Pages
- 949-956
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4313821
- OpenAlex
- W1979762144
- Cited by
- 133
- References
- 56
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 11 · 2020: 8 · 2019: 14 · 2018: 18 · 2017: 14 · 2016: 13 · 2015: 13
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | NIH | National Institute of Neurological Disorders and Stroke (1U54NS091859, NS089449)
- HHS | NIH | National Institute of General Medical Sciences (GM049245)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- FMRP, FMR1 gene, fragile X syndrome, presynaptic function, missense mutations, intellectual disability, seizures, neuromuscular junction, action potential broadening, BK channels, translational regulation, RNA binding, Drosophila, Fmr1 knockout mice
- MeSH terms
- Action Potentials, Animals, Child, Child, Preschool, Drosophila, Fragile X Syndrome, Gene Expression Regulation, Humans, Male, Seizures, Amino Acid Substitution, Mutation, Missense, Mice, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review